DUSAPHARMA.ORG

DUSA Pharmaceuticals, Inc. | Delivering Solutions for Dermatology®

December 20, 2012. Caraco Pharmaceutical Laboratories Announces Successful Tender Offer To Acquire DUSA. December 5, 2012. Caraco Pharmaceutical Laboratories and DUSA Pharmaceuticals Announce Early Termination of the Hart-Scott-Rodino Waiting Period Relating to Tender Offer. November 8, 2012. Sun Pharma to Acquire DUSA Pharmaceuticals, Inc. November 5, 2012. DUSA Pharmaceuticals, Inc. to Host Third Quarter 2012 Corporate Highlights and Financial Results Webcast and Conference Call. WEB 1401 Rev T.

http://www.dusapharma.org/

OVERVIEW OF dusapharma.org

TRAFFIC RANK

>1,000,000

REVIEWS

0

PAGES IN THIS WEBSITE

15

LINKS TO THIS WEBSITE

CONTACTS

ADDRESSES

SOCIAL LINKS

ONLINE SINCE

WEBSITE DETAILS

SEO

PAGES

SIMILAR SITES

TRAFFIC RANK FOR DUSAPHARMA.ORG

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

June

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Friday

TRAFFIC BY CITY

Sign up

CUSTOMER REVIEWS

Average Rating: 4.3 out of 5 with 13 reviews

5 star

9

4 star

1

3 star

2

2 star

0

1 star

1

Hey there! Start your review of dusapharma.org

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

LOAD TIME

0.5 seconds

FAVICON PREVIEW

16x16
32x32
64x64
128x128

CONTACTS AT DUSAPHARMA.ORG

DUSA Pharmaceuticals Inc

DUSA Pharmaceuticals Inc

25 Up●●●●●Drive

Wil●●●ton , MA, 01887

US

1.97●●●●7500

ge●●●●●●@dusapharma.com

View this contact

DUSA Pharmaceuticals Inc

DUSA Pharmaceuticals Inc

25 Up●●●●●Drive

Wil●●●ton , MA, 01887

US

1.97●●●●7500

ge●●●●●●@dusapharma.com

View this contact

DUSA Pharmaceuticals, Inc.

Ed Sinamark

25 Up●●●●●Drive

Wil●●●ton , MA, 01887

US

1.97●●●●2238

1.97●●●●1038

ef●@DUSAPHARMA.COM

View this contact

ADD CONTACT

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED: n/a
UPDATED: 2009 December 15
EXPIRATION: EXPIRED REGISTER THIS DOMAIN

BUY YOUR DOMAIN

NAME SERVERS

1: auth10.ns.wcom.com
2: auth50.ns.uu.net

REGISTRAR

Network Solutions, LLC (R63-LROR)

WHOIS : whois.publicinterestregistry.net

REFERRED :

CONTENT

PAGES IN
THIS WEBSITE

15

SSL

EXTERNAL LINKS

0

SITE IP

216.201.101.47

LOAD TIME

0.459 sec

SCORE

6.2

PAGE TITLE

DUSA Pharmaceuticals, Inc. | Delivering Solutions for Dermatology® | dusapharma.org Reviews

<META> DESCRIPTION

December 20, 2012. Caraco Pharmaceutical Laboratories Announces Successful Tender Offer To Acquire DUSA. December 5, 2012. Caraco Pharmaceutical Laboratories and DUSA Pharmaceuticals Announce Early Termination of the Hart-Scott-Rodino Waiting Period Relating to Tender Offer. November 8, 2012. Sun Pharma to Acquire DUSA Pharmaceuticals, Inc. November 5, 2012. DUSA Pharmaceuticals, Inc. to Host Third Quarter 2012 Corporate Highlights and Financial Results Webcast and Conference Call. WEB 1401 Rev T.

<META> KEYWORDS

1 about us

2 in the news

3 careers

4 for patients

5 for healthcare professionals

6 patients

7 reimbursement support

8 dusadelivers

9 healthcare professionals

10 about dusa

CONTENT

Page content here

KEYWORDS ON PAGE

about us,in the news,careers,for patients,for healthcare professionals,patients,reimbursement support,dusadelivers,healthcare professionals,about dusa,legal notice/privacy policy

SERVER

Apache

POWERED BY

PHP/5.2.17

CONTENT-TYPE

utf-8

GOOGLE PREVIEW

DUSA Pharmaceuticals, Inc. | Delivering Solutions for Dermatology® | dusapharma.org Reviews

https://dusapharma.org

December 20, 2012. Caraco Pharmaceutical Laboratories Announces Successful Tender Offer To Acquire DUSA. December 5, 2012. Caraco Pharmaceutical Laboratories and DUSA Pharmaceuticals Announce Early Termination of the Hart-Scott-Rodino Waiting Period Relating to Tender Offer. November 8, 2012. Sun Pharma to Acquire DUSA Pharmaceuticals, Inc. November 5, 2012. DUSA Pharmaceuticals, Inc. to Host Third Quarter 2012 Corporate Highlights and Financial Results Webcast and Conference Call. WEB 1401 Rev T.

INTERNAL PAGES

dusapharma.org

1

DUSA Pharmaceuticals, Inc. | Products

http://www.dusapharma.org/products-container.html

Aminolevulinic acid HCl) for Topical Solution, 20% plus blue light illumination using the BLU-U. Blue Light Photodynamic Therapy Illuminator is indicated for the treatment of minimally to moderately thick actinic keratoses of the face or scalp. In addition to its actinic keratoses indication (see above), BLU-U Blue Light Photodynamic Therapy is also a non-drug therapy for moderate acne. The BLU-U is a unique, specially designed blue light that kills the. WEB 1366 Rev M. Reimbursement / Insurance Support.

2

DUSA Pharmaceuticals, Inc. | Career Opportunities

http://www.dusapharma.org/careers.html

Raquo; About DUSA. DUSA Pharmaceuticals, Inc, a Sun Pharma company,. Is a fully integrated specialty pharmaceutical company focused primarily on the development and marketing of its Levulan. Photodynamic therapy (PDT) technology platform used in conjunction with its proprietary light source, the BLU-U. Blue Light Photodynamic Therapy Illuminator. Levulan Kerastick. Manager, Finance and Accounting-Billerica, MA location. Lead the annual budget development process; as well as the multi-year financial plan&...

3

DUSA Pharmaceuticals, Inc. | About the Company

http://www.dusapharma.org/about-dusa.html

Raquo; About DUSA. DUSA Pharmaceuticals, Inc. Is a fully integrated specialty pharmaceutical company focused primarily on the development and marketing of its Levulan. Aminolevulinic acid HCl) for Topical Solution, 20% photodynamic therapy (PDT) technology platform used in conjunction with it’s proprietary light source, the BLU-U. Levulan Kerastick (aminolevulinic acid HCl) for Topical Solution, 20%. BLU-U Blue Light Photodynamic Therapy Illuminator. WEB 1385 Rev K. Reimbursement / Insurance Support.

4

DUSA Pharmaceuticals, Inc. | Caraco Pharmaceutical Laboratories Announces Successful Tender Offer To Acquire DUSA

http://www.dusapharma.org/december-20-2012.html

Raquo; In the News. Raquo; December 20, 2012. Caraco Pharmaceutical Laboratories Announces Successful Tender Offer To Acquire DUSA. Director of Investor Relations. Caraco Pharmaceutical Laboratories Announces Successful Tender Offer. About Caraco Pharmaceutical Laboratories. Detroit-based Caraco Pharmaceutical Laboratories, Ltd. develops, manufactures, markets and distributes generic pharmaceuticals to the nation's largest wholesalers, distributors, drugstore chains and managed care providers.

5

DUSA Pharmaceuticals, Inc. | For Patients

http://www.dusapharma.org/for-patients.html

Raquo; For Patients. Learn how DUSA can help you manage your skin conditions. At DUSA, we are committed to developing innovative products that can help you manage skin conditions like actinic keratosis (AKs) and acne. To better understand AKs or acne, please review the basic information provided on this site. Aminolevulinic acid HCl) for Topical Solution, 20% plus blue light illumination using the BLU-U. And BLU-U PDT. It may be the right treatment for you. Is right for you. WEB 1455 Rev H.

UPGRADE TO PREMIUM TO VIEW 10 MORE

TOTAL PAGES IN THIS WEBSITE

15

OTHER SITES

dusapartment.com

Ruhig, zentral gelegene Zweiraum-Wohnung in Düsseldorf Pempelfort. Küche mit Essplatz und Wohn-Schlafraum). Zwei Balkone, davon einer zum ruhigen Innenhof. Ideale Verkehrsanbindung Bus Bahn (Flughafen, HBF, Messe).

dusaphama.com

dusaphama.com - This domain may be for sale!

Find the best information and most relevant links on all topics related to dusaphama.com. This domain may be for sale!

dusapharm.com